In Highlight
The Year in Cardiology 2027: Where Today’s Science Meets Tomorrow’s Care
Join leading experts for two days of cutting-edge science, clinical insights and global collaboration.
Discover event
Research
We fund and support scientific research to advance treatments and improve outcomes.
Education
We empower healthcare professionals with knowledge, training and best practices.
Global Impact
We work worldwide to ensure equitable access to quality heart failure care.
Better Lives
Our mission is simple: to save lives and improve heart health.
News
View all news →
Virtual Visits in Heart Failure: Mapping Use Before Judging Impact3 September 2025
Neighbourhood Deprivation and Heart Failure Outcomes: A Cohort Study24 June 2025Featured Videos
View all →
Latest Literature
View all →▤Predicting Incident Heart Failure: How Well Do Risk Models Validate?Research · 25 April 2026▤Biomarker-Guided Heart Failure Management: Why Certainty of Evidence MattersEvidence-Based Medicine · 17 April 2026▤HFpEF Pharmacotherapy: What a Network Meta-analysis ComparedCardiovascular Pharmacotherapy · 15 February 2026▤Dapagliflozin Started During Heart Failure Hospitalisation: DAPA ACT HF-TIMI 68Cardiovascular Pharmacotherapy · 4 December 2025
Upcoming Events
View all events →Latest Articles from PubMed
- Left ventricular ejection fraction recovery under contemporary quadruple guideline-directed therapy and the need for ICD/CRT-D implantation in HFrEF: a retrospective single-center cohort study
- Frailty as a Predictor of Outcomes After Fibula Free Flap for Head and Neck Reconstruction: A Multi-Institutional Analysis Using the mFI-5
- Prophylaxis Durations and Risks of Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients: An International, Multicenter Cohort Study
- Meta-analyses limitations and the compelling case for a contemporary, pragmatic trial of clopidogrel vs aspirin for secondary prevention of coronary heart disease: clopidogrel is not superior to aspirin in non-East Asian patients
- Protective effects of icariin in atherosclerotic cardiovascular disease: mechanistic basis, post-ischemic protection and translational limitations
- Socioeconomic Status and Cardiovascular Risk-Factor Burden in Patients Presenting With Premature ST-Elevation Myocardial Infarction
